ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugBridgeBio Pharma International GmbH
BridgeBio Pharma International GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

BridgeBio Pharma International GmbH develops and commercializes therapies for genetic diseases. The company focuses on research and clinical development of medicines and drug candidates for rare diseases, including several programs in late-stage clinical trials.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.7/5

BridgeBio Pharma International GmbH

✓ Offered2
Research and Drug Development Information
Information on research initiatives, therapeutic areas and products in development for general informational purposes; the website is not intended for medical advice, diagnosis or treatment.
Company and Location Information
Company information, contact options and legal notices for the international website, including privacy, cookie and terms information.
Trust & reputation

ranQ Trust Score of BridgeBio Pharma International GmbH: 3.7 out of 5.0

Trust Score3.7/ 5.0

Solid

x

Data basis 54% · As of October 2026

BridgeBio Pharma International GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
BridgeBio Pharma International GmbH scores 40.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.0.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
BridgeBio Pharma International GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
BridgeBio Pharma International GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

BridgeBio Pharma International GmbH reaches a ranQ Trust Score of 3.7 out of 5.0 — rated «Solid». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once BridgeBio Pharma International GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

BridgeBio Pharma International GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank BridgeBio Pharma International GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of BridgeBio Pharma International GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Landis + Gyr-Strasse 1
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-374.560.569
Founded
2026 · 0 years
Last commercial register change
July 8, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.88.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AS
    Alnylam Switzerland GmbH
    Zug
    CP
    Crinetics Pharmaceuticals Europe GmbH
    Zug
    NT
    Nektar Therapeutics Europe GmbH
    Zug
    CG
    Cilag GmbH International
    Zug
    EL
    Earendil Labs AG
    Zug
    NG
    Neopharmed Gentili Schweiz GmbH
    Zug
    IS
    Insmed Switzerland GmbH
    Zug
    VH
    ViiV Healthcare GmbH
    Baar